GFAP and neoplasm: The additional expression of EGFRvIII in this GEMM, either in a GFAP‐driven transgene or by adenoviral‐mediated gene transfer, both decreases disease‐free latency and increases tumor grade while also inducing oligodendroglial histological features 15, 84.